The FDA has opened the door to early access for daraxonrasib, a groundbreaking new drug showing remarkable promise against pancreatic cancer. This breakthrough ignites fresh hope for patients with few treatment options and represents a significant leap forward in the battle against this relentless disease
India has launched generic semaglutide, paving the way for more affordable and accessible treatments for diabetes and weight loss. This game-changing development marks a significant turning point in the market, aligning with thrilling global progress in obesity therapies
Health Canada has broadened the approval of Evkeeza® (evinacumab) to treat homozygous familial hypercholesterolemia (HoFH) in children as young as 6 months, offering exciting new hope for early and powerful treatment
Exciting news from Health Canada! They’ve broadened the approval of Jemperli (dostarlimab) in combination with chemotherapy for all adults facing primary advanced or first recurrent endometrial cancer. This groundbreaking treatment is the first in immuno-oncology to show a remarkable overall survival benefit.
